Sartorius Ag (NASDAQ:SARTF) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday.

According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “

Separately, DZ Bank AG reissued a “sell” rating on shares of Sartorius Ag in a research note on Friday, July 21st.

Sartorius Ag (NASDAQ:SARTF) opened at 96.00 on Friday. Sartorius Ag has a 52 week low of $75.00 and a 52 week high of $96.00. The company has a market cap of $6.57 billion and a P/E ratio of 54.45.

TRADEMARK VIOLATION WARNING: “Zacks Investment Research Downgrades Sartorius Ag (SARTF) to Hold” was published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international trademark and copyright law. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/09/16/zacks-investment-research-downgrades-sartorius-ag-sartf-to-hold-2.html.

Get a free copy of the Zacks research report on Sartorius Ag (SARTF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Sartorius Ag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Ag and related companies with MarketBeat.com's FREE daily email newsletter.